ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 133 filers reported holding ARRAY BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 16.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $225,000 | -19.6% | 14,796 | -11.2% | 0.01% | -20.0% |
| Q2 2018 | $280,000 | +65.7% | 16,665 | -58.5% | 0.01% | +42.9% |
| Q4 2015 | $169,000 | -73.0% | 40,164 | -70.8% | 0.01% | -75.9% |
| Q3 2015 | $627,000 | -26.7% | 137,435 | +15.9% | 0.03% | -6.5% |
| Q2 2015 | $855,000 | +114.8% | 118,534 | +119.5% | 0.03% | +121.4% |
| Q1 2015 | $398,000 | +155.1% | 53,992 | +63.9% | 0.01% | +180.0% |
| Q4 2014 | $156,000 | +169.0% | 32,937 | +156.0% | 0.01% | +150.0% |
| Q2 2013 | $58,000 | – | 12,867 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,556,586 | $215,946,000 | 10.65% |
| BVF INC/IL | 6,402,525 | $78,751,000 | 10.01% |
| First Light Asset Management, LLC | 1,469,461 | $18,074,000 | 5.72% |
| Avoro Capital Advisors LLC | 5,353,029 | $65,842,000 | 5.11% |
| EcoR1 Capital, LLC | 1,250,000 | $15,375,000 | 2.05% |
| Cormorant Asset Management, LP | 900,000 | $11,070,000 | 1.96% |
| NEXTHERA CAPITAL LP | 615,437 | $7,570,000 | 1.95% |
| Monashee Investment Management LLC | 418,000 | $5,141,000 | 1.94% |
| Orbimed Advisors | 14,182,900 | $174,450,000 | 1.67% |
| KOPP INVESTMENT ADVISORS LLC | 119,579 | $1,471,000 | 1.35% |